A prodrug of two approved drugs, cisplatin and chlorambucil, for chemo war against cancer

RK Pathak, R Wen, N Kolishetti, S Dhar - Molecular cancer therapeutics, 2017 - AACR
Cancer cells maintain normal mitochondrial glutathione as one of the defense mechanisms
to inhibit mitochondrial membrane polarization and hence apoptosis. A combinational …

Dual drug conjugated nanoparticle for simultaneous targeting of mitochondria and nucleus in cancer cells

A Mallick, P More, S Ghosh, R Chippalkatti… - … applied materials & …, 2015 - ACS Publications
Effective targeting of mitochondria has emerged as an alternative strategy in cancer
chemotherapy. However, considering mitochondria's crucial role in cellular energetics …

[HTML][HTML] Enhanced cytotoxicity to lung cancer cells by mitochondrial delivery of camptothecin

J Xie, H Wang, Q Huang, J Lin, H Wen, Y Miao… - European Journal of …, 2023 - Elsevier
Delivering traditional DNA-damaging anticancer drugs into mitochondria to damage
mitochondria is a promising chemotherapy strategy. The impermeability of this mitochondrial …

Mitochondrial-targeted nanoparticles: Delivery and therapeutic agents in cancer

C Ganji, V Muppala, M Khan, GP Nagaraju… - Drug discovery today, 2023 - Elsevier
Highlights•Dysregulation of mitochondrial metabolism is a hallmark of cancer development.•
Nanoparticles (NPs) enable the efficient and targeted delivery of mitochondrial agents.•NPs …

Mitochondria-targeted compounds in the treatment of cancer.

A Kafkova, J Trnka - Neoplasma, 2020 - search.ebscohost.com
Mitochondria are highly dynamic organelles involved in many cellular functions. Beyond
their central role in metabolism, they also take a part in maintaining calcium homeostasis …

[HTML][HTML] Treatment strategies that enhance the efficacy and selectivity of mitochondria-targeted anticancer agents

JS Modica-Napolitano, V Weissig - International journal of molecular …, 2015 - mdpi.com
Nearly a century has passed since Otto Warburg first observed high rates of aerobic
glycolysis in a variety of tumor cell types and suggested that this phenomenon might be due …

Mitochondrially targeted anti-cancer agents

L Biasutto, LF Dong, M Zoratti, J Neuzil - Mitochondrion, 2010 - Elsevier
Cancer is an ever-increasing problem that is yet to be harnessed. Frequent mutations make
this pathology very variable and, consequently, a considerable challenge. Intriguingly …

Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction

X Xue, S You, Q Zhang, Y Wu, G Zou… - Molecular …, 2012 - ACS Publications
Tumor resistance to chemotherapy is the major obstacle to employ cisplatin, one of the
broadly used chemotherapeutic drugs, for effective treatment of various tumors in the clinic …

[HTML][HTML] Recent progress in mitochondria-targeted drug and drug-free agents for cancer therapy

MT Jeena, S Kim, S Jin, JH Ryu - Cancers, 2019 - mdpi.com
The mitochondrion is a dynamic eukaryotic organelle that controls lethal and vital functions
of the cell. Being a critical center of metabolic activities and involved in many diseases …

Mitochondria as targets for established and novel anti-cancer agents

JM Grad, E Cepero, LH Boise - Drug Resistance Updates, 2001 - Elsevier
Chemoresistant cells have acquired the ability to evade the action of multiple classes of anti-
neoplastic compounds. One mechanism by which tumor cells survive in the presence of …